Clinical Trial Update: Tumor Necrosis Factor-alpha Levels and Cardiac Functions in Type 1 Diabetes Mellitus

View source ↗

Summary

This is a completed clinical trial evaluating tumor necrosis factor-alpha levels and cardiac function in individuals with Type 1 diabetes mellitus, focusing on …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Dysfunction
• Systolic Dysfunction
• Type 1 Diabetes Mellitus

Snippet

Sponsor: Sirnak State Hospital | Conditions: Diabetes Mellitus, Type 1, Systolic Dysfunction | Status: COMPLETED